Transforming Growth Factor-β–Activated Kinase 1 Regulates Angiogenesis via AMP-Activated Protein Kinase-α1 and Redox Balance in Endothelial Cells
Author(s) -
Nina Zippel,
Randa Abdel Malik,
Timo Frömel,
Rüdiger Popp,
Elke Bess,
Boris Strilić,
Nina Wettschureck,
Ingrid Fleming,
Beate Fißlthaler
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.301848
Subject(s) - microbiology and biotechnology , vascular endothelial growth factor a , vascular endothelial growth factor , angiogenesis , protein kinase a , chemistry , ampk , protein kinase b , endothelial stem cell , kinase , cancer research , biology , signal transduction , biochemistry , in vitro , vegf receptors
Transforming growth factor-β-activated kinase 1 (TAK1) is a mitogen-activated protein 3-kinase and an AMP-activated protein kinase (AMPK) kinase in some cell types. Although TAK1(-/-) mice display defects in developmental vasculogenesis, the role of TAK1 in endothelial cells has not been investigated in detail.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom